131 related articles for article (PubMed ID: 19255724)
1. No association of (-131C-->G) variant of CHI3L1 gene with risk of glioblastoma and prognosis.
Boisselier B; Marie Y; El Hallani S; Kaloshi G; Iershov A; Kavsan V; Psimaras D; Thillet J; Hoang-Xuan K; Delattre JY; Sanson M
J Neurooncol; 2009 Sep; 94(2):169-72. PubMed ID: 19255724
[TBL] [Abstract][Full Text] [Related]
2. Genetic variation in the promoter region of chitinase 3-like 1 is associated with atopy.
Sohn MH; Lee JH; Kim KW; Kim SW; Lee SH; Kim KE; Kim KH; Lee CG; Elias JA; Lee MG
Am J Respir Crit Care Med; 2009 Mar; 179(6):449-56. PubMed ID: 19106306
[TBL] [Abstract][Full Text] [Related]
3. Effect of variation in CHI3L1 on serum YKL-40 level, risk of asthma, and lung function.
Ober C; Tan Z; Sun Y; Possick JD; Pan L; Nicolae R; Radford S; Parry RR; Heinzmann A; Deichmann KA; Lester LA; Gern JE; Lemanske RF; Nicolae DL; Elias JA; Chupp GL
N Engl J Med; 2008 Apr; 358(16):1682-91. PubMed ID: 18403759
[TBL] [Abstract][Full Text] [Related]
4. Promoter polymorphisms in the chitinase 3-like 1 gene influence the serum concentration of YKL-40 in Danish patients with rheumatoid arthritis and in healthy subjects.
Nielsen KR; Steffensen R; Boegsted M; Baech J; Lundbye-Christensen S; Hetland ML; Krintel SB; Johnsen HE; Nyegaard M; Johansen JS
Arthritis Res Ther; 2011 Jun; 13(3):R109. PubMed ID: 21714862
[TBL] [Abstract][Full Text] [Related]
5. Chitinase-3-like 1 (CHI3L1) gene and schizophrenia: genetic association and a potential functional mechanism.
Yang MS; Morris DW; Donohoe G; Kenny E; O'Dushalaine CT; Schwaiger S; Nangle JM; Clarke S; Scully P; Quinn J; Meagher D; Baldwin P; Crumlish N; O'Callaghan E; Waddington JL; Gill M; Corvin A
Biol Psychiatry; 2008 Jul; 64(2):98-103. PubMed ID: 18281018
[TBL] [Abstract][Full Text] [Related]
6. High CHI3L1 expression is associated with glioma patient survival.
Steponaitis G; Skiriutė D; Kazlauskas A; Golubickaitė I; Stakaitis R; Tamašauskas A; Vaitkienė P
Diagn Pathol; 2016 Apr; 11():42. PubMed ID: 27121858
[TBL] [Abstract][Full Text] [Related]
7. Genetic polymorphisms in chitinase 3-like 1 (CHI3L1) are associated with circulating YKL-40 levels, but not with angiographic coronary artery disease in a Chinese population.
Zheng JL; Lu L; Hu J; Zhang RY; Zhang Q; Chen QJ; Shen WF
Cytokine; 2011 Apr; 54(1):51-5. PubMed ID: 21257319
[TBL] [Abstract][Full Text] [Related]
8. Significant Association of Chitinase 3-like 1 Genotypes to Asthma Risk in Taiwan.
Chen GL; Wang SC; Shen TC; Chang WS; Lin C; Hsia TC; Bau DT; Tsai CW
In Vivo; 2021; 35(2):799-803. PubMed ID: 33622872
[TBL] [Abstract][Full Text] [Related]
9. The chitinase 3-like 1 gene and schizophrenia: evidence from a multi-center case-control study and meta-analysis.
Ohi K; Hashimoto R; Yasuda Y; Yoshida T; Takahashi H; Iike N; Iwase M; Kamino K; Ishii R; Kazui H; Fukumoto M; Takamura H; Yamamori H; Azechi M; Ikezawa K; Tanimukai H; Tagami S; Morihara T; Okochi M; Yamada K; Numata S; Ikeda M; Tanaka T; Kudo T; Ueno S; Yoshikawa T; Ohmori T; Iwata N; Ozaki N; Takeda M
Schizophr Res; 2010 Feb; 116(2-3):126-32. PubMed ID: 20051317
[TBL] [Abstract][Full Text] [Related]
10. Plasma YKL-40 and CHI3L1 in systemic inflammation and sepsis-experience from two prospective cohorts.
Kornblit B; Hellemann D; Munthe-Fog L; Bonde J; Strøm JJ; Madsen HO; Johansen JS; Garred P
Immunobiology; 2013 Oct; 218(10):1227-34. PubMed ID: 23706599
[TBL] [Abstract][Full Text] [Related]
11. Genetic variation in chitinase 3-like 1 (CHI3L1) contributes to asthma severity and airway expression of YKL-40.
Gomez JL; Crisafi GM; Holm CT; Meyers DA; Hawkins GA; Bleecker ER; Jarjour N; ; Cohn L; Chupp GL
J Allergy Clin Immunol; 2015 Jul; 136(1):51-58.e10. PubMed ID: 25592985
[TBL] [Abstract][Full Text] [Related]
12. A functional variation in CHI3L1 is associated with severity of liver fibrosis and YKL-40 serum levels in chronic hepatitis C infection.
Berres ML; Papen S; Pauels K; Schmitz P; Zaldivar MM; Hellerbrand C; Mueller T; Berg T; Weiskirchen R; Trautwein C; Wasmuth HE
J Hepatol; 2009 Feb; 50(2):370-6. PubMed ID: 19070929
[TBL] [Abstract][Full Text] [Related]
13. Association of polymorphisms of the CHI3L1 gene with asthma and atopy: a populations-based study of 6514 Danish adults.
Rathcke CN; Holmkvist J; Husmoen LL; Hansen T; Pedersen O; Vestergaard H; Linneberg A
PLoS One; 2009 Jul; 4(7):e6106. PubMed ID: 19568425
[TBL] [Abstract][Full Text] [Related]
14. Integrated array-comparative genomic hybridization and expression array profiles identify clinically relevant molecular subtypes of glioblastoma.
Nigro JM; Misra A; Zhang L; Smirnov I; Colman H; Griffin C; Ozburn N; Chen M; Pan E; Koul D; Yung WK; Feuerstein BG; Aldape KD
Cancer Res; 2005 Mar; 65(5):1678-86. PubMed ID: 15753362
[TBL] [Abstract][Full Text] [Related]
15. CHI3L1 polymorphisms associate with asthma in a Taiwanese population.
Tsai Y; Ko Y; Huang M; Lin M; Wu C; Wang C; Chen Y; Li J; Tseng Y; Wang T
BMC Med Genet; 2014 Jul; 15():86. PubMed ID: 25056157
[TBL] [Abstract][Full Text] [Related]
16. A promoter variant in the chitinase 3-like 1 gene is associated with serum YKL-40 level and personality trait.
Yamamori H; Hashimoto R; Ohi K; Yasuda Y; Fukumoto M; Kasahara E; Sekiyama A; Umeda-Yano S; Okada T; Iwase M; Kazui H; Ito A; Takeda M
Neurosci Lett; 2012 Apr; 513(2):204-8. PubMed ID: 22366530
[TBL] [Abstract][Full Text] [Related]
17. A CHI3L1 gene polymorphism is associated with serum levels of YKL-40, a novel sarcoidosis marker.
Kruit A; Grutters JC; Ruven HJ; van Moorsel CC; van den Bosch JM
Respir Med; 2007 Jul; 101(7):1563-71. PubMed ID: 17236752
[TBL] [Abstract][Full Text] [Related]
18. YKL-40 expression is associated with poorer response to radiation and shorter overall survival in glioblastoma.
Pelloski CE; Mahajan A; Maor M; Chang EL; Woo S; Gilbert M; Colman H; Yang H; Ledoux A; Blair H; Passe S; Jenkins RB; Aldape KD
Clin Cancer Res; 2005 May; 11(9):3326-34. PubMed ID: 15867231
[TBL] [Abstract][Full Text] [Related]
19. Failure to confirm genetic association of the CHI3L1 gene with schizophrenia in Japanese and Chinese populations.
Yamada K; Hattori E; Iwayama Y; Toyota T; Ohnishi T; Iwata Y; Tsuchiya KJ; Sugihara G; Kikuchi M; Okazaki Y; Yoshikawa T
Am J Med Genet B Neuropsychiatr Genet; 2009 Jun; 150B(4):508-14. PubMed ID: 18767121
[TBL] [Abstract][Full Text] [Related]
20. Extent of tumor removal and molecular markers in cerebral glioblastoma: a combined prognostic factors study in a surgical series of 105 patients.
Salvati M; Pichierri A; Piccirilli M; Floriana Brunetto GM; D'Elia A; Artizzu S; Santoro F; Arcella A; Giangaspero F; Frati A; Simione L; Santoro A
J Neurosurg; 2012 Aug; 117(2):204-11. PubMed ID: 22655594
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
